4//SEC Filing
STEINMETZ MICHAEL 4
Accession 0001209191-08-008192
CIK 0001301081other
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 7:13 PM ET
Size
29.3 KB
Accession
0001209191-08-008192
Insider Transaction Report
Form 4
Pharmasset IncVRUS
BAB BIO VENTURES NV
10% Owner
Transactions
- Other
Common Stock
2008-02-04+35,558→ 35,558 total(indirect: See Footnote) - Sale
Common Stock
2008-02-04$23.86/sh−27,300$651,378→ 2,623,832 total(indirect: See Footnote) - Other
Common Stock
2008-02-04−1,500,000→ 2,651,132 total(indirect: See Footnote) - Other
Common Stock
2008-02-04+57,353→ 57,353 total(indirect: See Footnote) - Other
Common Stock
2008-02-04+27,925→ 27,925 total(indirect: See Footnote)
MPM BIOVENTURES PARALLEL FUND L P
10% Owner
Transactions
- Other
Common Stock
2008-02-04+35,558→ 35,558 total(indirect: See Footnote) - Other
Common Stock
2008-02-04−1,500,000→ 2,651,132 total(indirect: See Footnote) - Sale
Common Stock
2008-02-04$23.86/sh−27,300$651,378→ 2,623,832 total(indirect: See Footnote) - Other
Common Stock
2008-02-04+27,925→ 27,925 total(indirect: See Footnote) - Other
Common Stock
2008-02-04+57,353→ 57,353 total(indirect: See Footnote)
BB BIOVENTURES L P
10% Owner
Transactions
- Other
Common Stock
2008-02-04−1,500,000→ 2,651,132 total(indirect: See Footnote) - Sale
Common Stock
2008-02-04$23.86/sh−27,300$651,378→ 2,623,832 total(indirect: See Footnote) - Other
Common Stock
2008-02-04+57,353→ 57,353 total(indirect: See Footnote) - Other
Common Stock
2008-02-04+35,558→ 35,558 total(indirect: See Footnote) - Other
Common Stock
2008-02-04+27,925→ 27,925 total(indirect: See Footnote)
Transactions
- Sale
Common Stock
2008-02-04$23.86/sh−27,300$651,378→ 2,623,832 total(indirect: See Footnote) - Other
Common Stock
2008-02-04+27,925→ 27,925 total(indirect: See Footnote) - Other
Common Stock
2008-02-04+57,353→ 57,353 total(indirect: See Footnote) - Other
Common Stock
2008-02-04−1,500,000→ 2,651,132 total(indirect: See Footnote) - Other
Common Stock
2008-02-04+35,558→ 35,558 total(indirect: See Footnote)
BAB BIO VENTURES LLP
10% Owner
Transactions
- Sale
Common Stock
2008-02-04$23.86/sh−27,300$651,378→ 2,623,832 total(indirect: See Footnote) - Other
Common Stock
2008-02-04−1,500,000→ 2,651,132 total(indirect: See Footnote) - Other
Common Stock
2008-02-04+57,353→ 57,353 total(indirect: See Footnote) - Other
Common Stock
2008-02-04+35,558→ 35,558 total(indirect: See Footnote) - Other
Common Stock
2008-02-04+27,925→ 27,925 total(indirect: See Footnote)
EVNIN LUKE
Other
Transactions
- Other
Common Stock
2008-02-04+35,558→ 35,558 total(indirect: See Footnote) - Other
Common Stock
2008-02-04−1,500,000→ 2,651,132 total(indirect: See Footnote) - Sale
Common Stock
2008-02-04$23.86/sh−27,300$651,378→ 2,623,832 total(indirect: See Footnote) - Other
Common Stock
2008-02-04+57,353→ 57,353 total(indirect: See Footnote) - Other
Common Stock
2008-02-04+27,925→ 27,925 total(indirect: See Footnote)
STEINMETZ MICHAEL
10% Owner
Transactions
- Other
Common Stock
2008-02-04+57,353→ 57,353 total(indirect: See Footnote) - Other
Common Stock
2008-02-04−1,500,000→ 2,651,132 total(indirect: See Footnote) - Other
Common Stock
2008-02-04+27,925→ 27,925 total(indirect: See Footnote) - Sale
Common Stock
2008-02-04$23.86/sh−27,300$651,378→ 2,623,832 total(indirect: See Footnote) - Other
Common Stock
2008-02-04+35,558→ 35,558 total(indirect: See Footnote)
MPM BIOVENTURES I LP
10% Owner
Transactions
- Other
Common Stock
2008-02-04+35,558→ 35,558 total(indirect: See Footnote) - Other
Common Stock
2008-02-04+57,353→ 57,353 total(indirect: See Footnote) - Other
Common Stock
2008-02-04−1,500,000→ 2,651,132 total(indirect: See Footnote) - Other
Common Stock
2008-02-04+27,925→ 27,925 total(indirect: See Footnote) - Sale
Common Stock
2008-02-04$23.86/sh−27,300$651,378→ 2,623,832 total(indirect: See Footnote)
MPM BIO VENTURES I LLC
10% Owner
Transactions
- Sale
Common Stock
2008-02-04$23.86/sh−27,300$651,378→ 2,623,832 total(indirect: See Footnote) - Other
Common Stock
2008-02-04+35,558→ 35,558 total(indirect: See Footnote) - Other
Common Stock
2008-02-04−1,500,000→ 2,651,132 total(indirect: See Footnote) - Other
Common Stock
2008-02-04+27,925→ 27,925 total(indirect: See Footnote) - Other
Common Stock
2008-02-04+57,353→ 57,353 total(indirect: See Footnote)
GADICKE ANSBERT
10% Owner
Transactions
- Sale
Common Stock
2008-02-04$23.86/sh−27,300$651,378→ 2,623,832 total(indirect: See Footnote) - Other
Common Stock
2008-02-04+57,353→ 57,353 total(indirect: See Footnote) - Other
Common Stock
2008-02-04+35,558→ 35,558 total(indirect: See Footnote) - Other
Common Stock
2008-02-04−1,500,000→ 2,651,132 total(indirect: See Footnote) - Other
Common Stock
2008-02-04+27,925→ 27,925 total(indirect: See Footnote)
Footnotes (9)
- [F1]Pro rata distribution of partnership interests.
- [F2]These shares were distributed as follows: 685,501 shares by BB BioVentures, L.P. ("BBBV"), 92,412 shares by MPM BioVentures Parallel Fund, L.P. ("BV PF"), 8,175 shares by MPM Asset Management Investors 1999 LLC ("AM 1999"), 39,814 shares by MPM BioVentures III, L.P., ("BV III"), 592,101 shares by MPM BioVentures III-QP, L.P. ("BV III QP"), 50,038 shares held by MPM BioVentures III GmbH & Co. Beteiligungs KG ("BV KG"), 17,883 shares by MPM BioVentures III Parallel Fund, L.P. ("BV III PF") and 14,076 shares held by MPM Asset Management Investors 2004 BVIII LLC ("AM BV III"). MPM BioVentures I, L.P. ("BV I") and MPM BioVentures I LLC ("BV I LLC") are the direct and indirect general partners of BV PF. BAB BioVentures L.P. ("BAB BV"), BAB BioVentures, N.V. ("BAB NV") and BV I LLC are the direct and indirect general partners of BBBV. Luke Evnin, Michael Steinmetz and Ansbert Gadicke are the managers of AM 1999 and BV I LLC. MPM BioVentures III GP, L.P. ("BV III GP") and MPM BioVentures III LLC ("BV III LLC") are the direct and indirect general partners of BV III, BV III QP, BV III PF and BV KG. Luke Evnin, Michael Steinmetz and Ansbert Gadicke are members of BV III LLC and AM BV III. Each Reporting Person disclaims beneficial ownership of all such shares except to the extent of their respective proportionate pecuniary interests therein.
- [F3]On October 18, 2007, additional shares were received pursuant to a declaration of a stock dividend as follows: 7,745 by BBBV, 879 by BV PF, 90 by AM 1999, 2,672 by BV III, 39,748 by BV III QP, 3,359 by BV KG, 1,200 by BV III PF and 944 by AM BV III.
- [F4]The shares are held as follows: 1,211,570 by BBBV, 163,332 by BV PF, 14,448 by AM 1999, 70,369 by BV III, 1,046,493 by BV III QP, 88,437 by BV KG, 31,606 by BV III PF and 24,877 by AM BV III. Each Reporting Person disclaims beneficial ownership of all such shares except to the extent of their respective proportionate pecuniary interests therein.
- [F5]The shares were sold as follows: 12,476 by BBBV, 1,682 by BV PF, 149 by AM 1999, 725 by BV III, 10,776 by BV III QP, 911 by BV KG, 325 by BV III PF and 256 by AM BV III.
- [F6]The shares are held as follows: 1,199,094 by BBBV, 161,650 by BV PF, 14,299 by AM 1999, 69,644 by BV III, 1,035,717 by BV III QP, 87,526 by BV KG, 31,281 by BV III PF and 24,621 by AM BV III. Each Reporting Person disclaims beneficial ownership of all such shares except to the extent of their respective proportionate pecuniary interests therein.
- [F7]The shares are held by Luke Evnin.
- [F8]The shares are held by Michael Steinmetz.
- [F9]The shares are held as follows: 29,369 by Ansbert Gadicke and 6,189 by The Gadicke Irrevocable Trust, of which Mr. Gadicke is a trustee. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
Documents
Issuer
Pharmasset Inc
CIK 0001301081
Entity typeother
Related Parties
1- filerCIK 0001166285
Filing Metadata
- Form type
- 4
- Filed
- Feb 5, 7:00 PM ET
- Accepted
- Feb 6, 7:13 PM ET
- Size
- 29.3 KB